-
Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023
-
View Affiliations Hide AffiliationsMiguel Angel Sanchez Ruizsanchez.r.miguel.angel gmail.com
-
View Collaborators
ESURE SARI group: Pello Latasa Zamalloa, Fernando Gonzalez Carril, Liher Imaz Goienetxea, Mikel Ogueta Lana, Eduardo Inchausti Artesero, Aitziber Etxagibel Galdo, Jon Eziolaza Sainz Trapaga, Alba Moya Garcés, Carlota Ruiz de Porras, Luca Basile, Jacobo Mendioroz, María-Teresa Otero-Barrós, Olaia Pérez-Martínez, Ana Sofia Lameiras Azevedo, Miriam López Torrijos, Anthony NardoneView Citation Hide Citation
Citation style for this article: . Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023. Euro Surveill. 2025;30(27):pii=2400748. https://doi.org/10.2807/1560-7917.ES.2025.30.27.2400748 Received: 08 Nov 2024; Accepted: 26 Feb 2025
Abstract
Surveillance of severe acute respiratory infections (SARI) using ICD-10 codes from electronic health records (EHR) lacks consensus on optimal case-defining codes.
We determined codes that maximise sensitivity (Se) and positive predictive value (PPV) for SARI associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus and respiratory syncytial virus (RSV) in Denmark, Iceland, Malta, Norway and Spain.
We included hospitalisations from week 21/2021 to 39/2023, with ICD-10 diagnostic codes for respiratory disease (three-character codes J00–J99) or COVID-19 (U07.1, U07.2, country-specific codes for Denmark). We assessed Se and PPV of individual codes against laboratory results. Based on Se and PPV rank-sum, we selected the top 10 codes and combined them into 10 sets per pathogen. We identified sets that maximised the clinical utility index (CUI = Se × PPV), categorised as excellent (≥ 0.81), good (0.64–0.80), satisfactory (0.49–0.63) and poor (< 0.49).
We assessed 395,163 hospitalisations for SARI-SARS-CoV-2, 313,418 for SARI-influenza and 192,936 for SARI-RSV, all tested. For SARI-SARS-CoV-2, code U07.1 (B34.2A, B97.2A for Denmark) had excellent utility in Denmark, Malta, Norway, Spain (≥ 0.82), and good utility in Iceland (0.79). For SARI-influenza, J09, J10 and J11 performed excellently in Denmark, Norway, Spain (≥ 0.83), satisfactorily in Malta (0.52), and poorly in Iceland (0.43). For SARI-RSV, J12, J20 and J21 achieved highest CUI but had poor utility (0.17–0.34).
COVID-19- and influenza-specific three-character ICD-10 codes accurately identified SARI associated with SARS-CoV-2 and influenza virus. For SARI-RSV, four-character codes should be explored. We recommend context-specific assessments in countries adopting EHR-based surveillance.

Full text loading...
